Chemed Co. (NYSE:CHE) Shares Sold by Renaissance Technologies LLC

Renaissance Technologies LLC lowered its holdings in Chemed Co. (NYSE:CHE) by 1.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 47,100 shares of the company’s stock after selling 654 shares during the period. Renaissance Technologies LLC owned about 0.31% of Chemed worth $24,954,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. HighTower Advisors LLC increased its holdings in shares of Chemed by 78.0% in the third quarter. HighTower Advisors LLC now owns 3,730 shares of the company’s stock valued at $2,246,000 after buying an additional 1,634 shares in the last quarter. Quantinno Capital Management LP raised its position in shares of Chemed by 29.9% during the third quarter. Quantinno Capital Management LP now owns 1,587 shares of the company’s stock worth $954,000 after purchasing an additional 365 shares during the period. National Bank of Canada FI acquired a new stake in shares of Chemed during the third quarter worth $1,496,000. MML Investors Services LLC lifted its holdings in shares of Chemed by 3.9% during the third quarter. MML Investors Services LLC now owns 1,457 shares of the company’s stock valued at $876,000 after purchasing an additional 55 shares during the last quarter. Finally, Geode Capital Management LLC boosted its position in shares of Chemed by 4.9% in the 3rd quarter. Geode Capital Management LLC now owns 335,443 shares of the company’s stock valued at $201,820,000 after purchasing an additional 15,791 shares during the period. 95.85% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the stock. Royal Bank of Canada upped their price objective on shares of Chemed from $633.00 to $667.00 and gave the company an “outperform” rating in a research note on Friday, March 14th. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research report on Friday, March 7th.

Insider Activity

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the completion of the sale, the chief executive officer now owns 102,679 shares of the company’s stock, valued at $60,957,441.93. This trade represents a 1.91 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. 3.32% of the stock is owned by corporate insiders.

Chemed Trading Up 0.2 %

Shares of CHE stock opened at $591.44 on Friday. The company has a market capitalization of $8.64 billion, a price-to-earnings ratio of 29.89, a P/E/G ratio of 2.15 and a beta of 0.49. Chemed Co. has a 1-year low of $512.12 and a 1-year high of $625.09. The stock’s fifty day simple moving average is $583.16 and its 200-day simple moving average is $567.95.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 annualized dividend and a yield of 0.34%. Chemed’s dividend payout ratio (DPR) is presently 10.05%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.